DEINOVE and GREENTECH announce the launch of HEBELYS, their first cosmetic active

DEINOVE and GREENTECH announce the launch of HEBELYS, their first cosmetic active

DEINOVE AND GREENTECH ANNOUNCE HEBELYS LAUNCH ® , THE FIRST COSMETIC ASSUMPTION FROM THEIR COLLABORATION HEBELYS® is a natural active ingredient produced by fermentation of Sphingomonas , a bacterium from the DEINOVE proprietary strain library. He demonstrated during tests his ability to preserve the youth of the skin, through its action on various aging factors and in particular on a protein involved in the process of cellular senescence. This new asset will be presented during the show In-Cosmetics in Amsterdam (17-19 April). Montpellier, April 16, 2018 (07:30 CEST) – DEINOVE (Euronext Growth Paris: ALDEI), a biotechnology company that discovers, develops and produces compounds with high added value from rare bacteria, and GREENTECH, a major player in the production and distribution of ingredients derived from biotechnology, today announced the launch of HEBELYS®, the first anti-aging active from the collaboration launched in March 2017 [1] . HEBELYS® will be presented on the GREENTECH stand at the show In-cosmetics Global which takes place in Amsterdam from 17 to 19 April 2018. This anti-aging active ingredient is obtained by fermentation of a bacterium of the genus Sphingomonas , a rare microorganism from the DEINOVE strain library. During testing, HEBELYS® has demonstrated its ability to preserve youthful skin , acting on different parameters: protection against oxidation, stimulation of the synthesis of collagen, elastin, fibrillin. HEBELYS® has in particular a significant and demonstrated action on the expression of the p16 protein IINK4A , a key factor in premature cell aging. Under the effect of HEBELYS®, the skin is protected, it regains density, flexibility and elasticity. She is visibly rejuvenated. HEBELYS® is the first ingredient resulting from the collaboration between DEINOVE and GREENTECH, fruit of the alliance of complementary skills: DEINOVE has selected the strain, developed the production process to achieve optimal fermentation performances and supervised the tests. in vitro intended to characterize the extract; GREENTECH has developed the formulation process, validated the stability and the safety as well as the efficiency by tests ex vivo additional. HEBELYS® will be marketed effectively by GREENTECH. Jean-Yves Berthon, CEO of GREENTECH, states: “This first collaboration is a real success. HEBELYS ® is a very nice asset, totally in line with our catalog and our ambition to offer the cosmetic industry high-tech active ingredients. ” Emmanuel PETIOT, Managing Director of DEINOVE adds: “The joint work of two teams has been very rewarding. We are proud to have responded to GREENTECH’s expectations in terms of innovation and achieved so quickly to a commercial product, we intend to continue in this direction. ” ABOUT GREENTECH A pioneer in plant biotechnology since its creation in 1992, GREENTECH develops and produces high-tech active ingredients from the plant, marine and microbial worlds for cosmetics, pharmaceuticals and nutraceuticals. With more than 100 active ingredients and 3000 extracts, GREENTECH’s portfolio meets all skin requirements and needs, regardless of functionality or age. The GREENTECH Group, with its 3 companies, GREENTECH, GREENSEA and BIOVITIS, has 3 subsidiaries in Germany, the United States and Brazil; it is present on all continents, in more than 30 countries around the world, thanks to a network of local distributors. contacts ABOUT DEINOVE DEINOVE (Euronext Growth Paris: ALDEI) is a biotechnology company that discovers, develops and produces compounds with high added value from rare microorganisms for the health, nutrition and cosmetics sectors. For this, DEINOVE relies on two key assets: A unique strain in the world of 6000 rare and still unexploited bacteria; A proprietary genetic, metabolic and fermentation engineering platform that allows it to transform these natural micro-factories into new industrial standards. Based in Montpellier, DEINOVE employs around 55 people and has filed more than 130 international patents. The Company has been listed on Euronext growth since April 2010. contacts www. [1] Press release of March 27, 2017 Attachment

Leave a comment

Send a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.